TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease

Cited by (378)

Items 201–300 of 378

  1. Astrocytes and Microglia in Alzheimer's Disease: Friends, Foes, or Both?
    Amit Sharma, Bhavin K Parekh, Vinay Patil, Renuka Jyothi S., Priya Priyadarshini Nayak, J Bethanney Janney, Gurjant Singh, Shaker Al-Hasnaawei · 2025 · Developmental Neurobiology
  2. HuM195 and its single-chain variable fragment increase Aβ phagocytosis in microglia via elimination of CD33 inhibitory signaling
    Eitan Wong, Manish Malviya, Tanya Jain, George Paul Liao, Zoe Kehs, Jerry C. Chang, Lorenz Studer, David A. Scheinberg, Yue‐Ming Li · 2024 · Molecular Psychiatry
  3. Association between hippocampal microglia, AD and LATE‐NC, and cognitive decline in older adults
    Alifiya Kapasi, Lei Yu, Sue E. Leurgans, Sonal Agrawal, Patricia A. Boyle, David Alan Bennett, Julie A. Schneider · 2024 · Alzheimer s & Dementia
  4. Microglia signaling in health and disease – Implications in sex-specific brain development and plasticity
    Subrata Pramanik, Harini Devi M., Saswata Chakrabarty, Berkay Paylar, Ajay Pradhan, Manisha Thaker, Shamini Ayyadhury, Arulmani Manavalan, Per‐Erik Olsson, Gopal Pramanik et al. · 2024 · Neuroscience & Biobehavioral Reviews
  5. A review of imaging genetics in Alzheimer's disease
    Xin Yu, Jinhua Sheng, Miao Miao, Luyun Wang, Ze Xiao Yang, He Huang · 2022 · Journal of Clinical Neuroscience
  6. The gain-of-function TREM2-T96K mutation increases risk for Alzheimer’s disease by impairing microglial function
    Pilat, Dominika J., Le, Hoang, Prokopenko, Dmitry, Lin, Chih-Chung Jerry, Eimer, William A., Quinti, Luisa, Gavrilles, Evan P., Garcia, Sheyla N., Heitman, Sara N., McGinty, Danielle et al. · 2026 · Neuron
  7. TREM2 and microglial immunity in Alzheimer’s disease: mechanisms, genetics, and therapeutic opportunities
    Wang, Tianqing, Liu, Xinru, Wang, Xifeng, Hua, Fuzhou, Yan, Lei · 2026 · Frontiers in Immunology
  8. MEK1/2 activity modulates TREM2 cell surface recruitment
    Jason Schapansky, Yelena Y. Grinberg, David M. Osiecki, Emily A. Freeman, Stephen G. Walker, Eric H. Karran, Sujatha M. Gopalakrishnan, Robert V. Talanian · 2020 · Journal of Biological Chemistry
  9. The emerging role of the microglia triggering receptor expressed on myeloid cells (TREM) 2 in multiple sclerosis
    Mahan Farzan, Masoumeh Saberi Rounkian, Atefeh Asadi Rizi, Zahra Heidari, Mahour Farzan, Mobina Fathi, Ava Aghaei, Fatemeh Azadegan‐Dehkordi, Nader Bagheri · 2024 · Experimental Neurology
  10. Can Anti–β-amyloid Monoclonal Antibodies Work in Autosomal Dominant Alzheimer Disease?
    Bruno Pietro Imbimbo, Ugo Lucca, Mark I L Watling · 2020 · Neurology Genetics
  11. Novel potent liposome agonists of triggering receptor expressed on myeloid cells 2 phenocopy antibody treatment in cells
    Christophe Boudesco, Annelies Nonneman, Alessandro Cinti, Paola Picardi, Loredana Redaelli, Sofie Swijsen, Julian Roewe, Peter Reinhardt, Melanie Ibach, Jochen Walter et al. · 2022 · Glia
  12. Targeting CD38 immunometabolic checkpoint improves metabolic fitness and cognition in a mouse model of Alzheimer’s disease
    Javier María Peralta Ramos, Giulia Castellani, Denise Kviatcovsky, Tommaso Croese, Afroditi Tsitsou-Kampeli, Chiara Burgaletto, Miguel Angel Abellanas, Liora Cahalon, Sarah Phoebeluc Colaiuta, Tomer‐Meir Salame et al. · 2025 · Nature Communications
  13. Microglial Dysfunction and Amyloid-Beta Pathology in Alzheimer’s Disease and HIV-Associated Neurocognitive Disorders
    George Chigozie Njoku, Georgette D. Kanmogne · 2025 · International Journal of Molecular Sciences
  14. Alzheimer’s Disease-Associated Alternative Splicing of CD33 Is Regulated by the HNRNPA Family Proteins
    Riho Komuro, Yuka Honda, Motoaki Yanaizu, Masami Nagahama, Yoshihiro Kino · 2023 · Cells
  15. Emerging roles for ITAM and ITIM receptor signaling in microglial biology and Alzheimer's disease‐related amyloidosis
    Joshua D. Samuels, John R. Lukens, Richard J. Price · 2023 · Journal of Neurochemistry
  16. The Pathogenesis in Alzheimer's Disease: TREM2 as a Potential Target
    Guangtong Liu, Linlin Zhang, Yongzhao Fan, Wenliang Ji · 2023 · Journal of Integrative Neuroscience
  17. Analysis of Genetic Variants Associated with Levels of Immune Modulating Proteins for Impact on Alzheimer’s Disease Risk Reveal a Potential Role for SIGLEC14
    Benjamin C. Shaw, Yuriko Katsumata, James F. Simpson, David W. Fardo, Steven Estus · 2021 · Genes
  18. Uncovering neuroinflammation-related modules and potential repurposing drugs for Alzheimer's disease through multi-omics data integrative analysis
    Li, Shensuo, Lu, Changhao, Zhao, Zhenzhen, Lu, Dong, Zheng, Guangyong · 2023 · Frontiers in Aging Neuroscience
  19. The Neuro-Inflammatory Microenvironment: An Important Regulator of Stem Cell Survival in Alzheimer’s Disease
    Zhiwei Shen, Xinyi Yang, Yu‐Long Lan, Gao Chen · 2024 · Journal of Alzheimer s Disease
  20. Functional insight into LOAD-associated microglial response genes
    Lauren A. Jonas, Tanya Jain, Yue‐Ming Li · 2022 · Open Biology
  21. Anti-Inflammatory Activity of Panduratin A against LPS-Induced Microglial Activation
    Sopana Jamornwan, Tanida Chokpanuwat, Kwanchanok Uppakara, Sunhapas Soodvilai, Witchuda Saengsawang · 2022 · Biomedicines
  22. Identification of common core ion channel genes in epilepsy and Alzheimer’s disease
    Ting Seng Tang, Xiang Li, Erhan Yu, Man Li, Xiaodong Pan · 2023 · Irish Journal of Medical Science (1971 -)
  23. CD33 mRNA Has Elevated Expression Levels in the Leukocytes of Peripheral Blood in Patients with Late-Onset Alzheimer’s Disease
    Fatemeh Heidari, George Ansstas, Farzam Ajamian · 2021 · Gerontology
  24. Beyond the classical amyloid hypothesis in Alzheimer's disease: Molecular insights into current concepts of pathogenesis, therapeutic targets, and study models
    Atsadang Theerasri, Sakawrat Janpaijit, Tewin Tencomnao, Anchalee Prasansuklab · 2022 · WIREs Mechanisms of Disease
  25. HIF-1α-induced microglia-mediated neuroinflammation is involved in Alzheimer's disease: Evidence from single-cell transcriptomic analysis
    Manyu Dong, Yilun Qian, Yao Geng, Ruiyu Wang, Yu Wang, Jili Cai, Xihui Wang, Ying Huang, Yan Liu, Wentao Liu et al. · 2025 · Journal of Alzheimer s Disease
  26. A Function of Amyloid-β in Mediating Activity-Dependent Axon/Synapse Competition May Unify Its Roles in Brain Physiology and Pathology
    Zhen Huang · 2023 · Journal of Alzheimer s Disease
  27. Analysis of the correlation between immune cell characteristics and insomnia: a Mendelian randomization study
    Yupeng Han, Zhiwei Song, Wangyu Li, Peng Ke, Xiaodan Wu · 2023 · Journal of Neurophysiology
  28. Neutrophils in the Focus: Impact on Neuroimmune Dynamics and the Gut–Brain Axis
    Antea Kršek, Lara Batičić · 2024 · Gastrointestinal Disorders
  29. Immune modulations and immunotherapies for Alzheimer’s disease: a comprehensive review
    Sara Mahdiabadi, Sara Momtazmanesh, George L. Perry, Nima Rezaei · 2021 · Reviews in the Neurosciences
  30. Immune cells in Alzheimer’s disease: insights into pathogenesis and potential therapeutic targets
    Xiaofeng Fu, Huimin Cai, Shuiyue Quan, Ziye Ren, Yuyun Xu, Longfei Jia · 2024 · Medical Review
  31. Targeting the chemokine-microglia nexus: A novel strategy for modulating neuroinflammation in Alzheimer's disease
    Bingyang Xu, Chao Tang, Rongshou Han, Chaomin Zhu, Yuxuan Yang, Henry James Li, Ning Wu, Dian He · 2025 · Journal of Alzheimer s Disease Reports
  32. Proliferating Microglia Exhibit Unique Transcriptional and Functional Alterations in Alzheimer’s Disease
    Nàdia Villacampa, Heela Sarlus, Paula Martorell, Khushbu Bhalla, Sergio Castro‐Gomez, Ana Maria Menezes Vieira-Saecker, Ilya Slutzkin, Kristian Händler, Carmen Venegas, Róisín M. McManus et al. · 2025 · ASN NEURO
  33. Biologics as Therapeutical Agents Under Perspective Clinical Studies for Alzheimer’s Disease
    Huan Li, Xiaoxia Shen, Beiyu Zhang, Zheying Zhu · 2025 · Molecules
  34. Siglec-15 as a New Perspective Therapy Target in Human Giant Cell Tumor of Bone
    Mengke Fan, Guochuan Zhang, Mingfang Xie, Xinbo Liu, Qi Zhang, Ling Wang · 2022 · Current Oncology
  35. Neuronal ablation of GHSR mitigates diet-induced depression and memory impairment via AMPK-autophagy signaling-mediated inflammation
    Hongying Wang, Zheng Shen, Chia‐Shan Wu, Pengfei Ji, Ji Yeon Noh, Cédric G. Geoffroy, Sun-Ja Kim, David W. Threadgill, Jianrong Li, Yu Zhou et al. · 2024 · Frontiers in Immunology
  36. Cholesterol 24-hydroxylase at the choroid plexus contributes to brain immune homeostasis
    Afroditi Tsitsou-Kampeli, Stefano Suzzi, Mor Kenigsbuch, Akisawa Satomi, Romano Strobelt, Oded Singer, Ester Feldmesser, Maitreyee Purnapatre, Sarah Phoebeluc Colaiuta, Eyal David et al. · 2023 · Cell Reports Medicine
  37. Natural medicine HLXL targets multiple pathways of amyloid-mediated neuroinflammation and immune response in treating alzheimer's disease
    Yingxia Liang, David Y.W. Lee, Sherri Y. Zhen, Haoqi Sun, Biyue Zhu, Jing Liu, Dan Lei, Chih‐Chung Lin, Siyi Zhang, Nicholas A. Jacques et al. · 2022 · Phytomedicine
  38. Mechanisms of increased Alzheimer’s disease pathology with R47H and R62H TREM2 variants
    Nurun Nahar Fancy, Nanet Willumsen, Vicky M. N. Chau, Samuel L Boulger, Harry J. Whitwell, Wenhao Wang, Baptiste Avot, Michael Thomas, Jonathan Talbot-Martin, Stergios Tsartsalis et al. · 2026 · Acta Neuropathologica
  39. Senescent microglia: The hidden culprits accelerating Alzheimer’s disease
    Wu Li, Yongyan Xie, Mu Jia-Xin, Ge Shu-Chao, Huang Li-Ping · 2025 · Brain Research
  40. Macrophages Atp6v0d2 regulates XBP1-mediated cholesterol metabolism to suppress metabolic dysfunction-associated steatohepatitis progression
    Ziyi Wang, Xuejiao Chen, Jie Li, Minhao Chen, Haoliang Zhu, Xiang‐dong Li, Wenjie Yu, Nan L. Xia, Yu Zhang, Linfeng Sun et al. · 2025 · International Immunopharmacology
  41. Sterile innate immune mechanisms in neurodegenerative diseases
    Alyssa Ealy, Amanda M Serapiglia, Nikhil Panicker · 2025 · Journal of Biological Chemistry
  42. Role of TREM2 in neuroinflammation regulation: mechanisms, disease associations, and therapeutic translation advances
    Yinsheng Liao, Guo Mu, Shengfeng Deng, Bin Feng Lu, Maoyao Zheng · 2025 · Journal of Translational Medicine
  43. Causal relationship between circulating immune cells and the risk of Alzheimer's disease: A Mendelian randomization study
    Hua Xue, Jiajia Chen, Li Zeng, Wenhui Fan · 2024 · Experimental Gerontology
  44. A systematic review of the role of TREM2 in Alzheimer’s disease
    Yunsi Yin, Han-Chen Yang, Ruiyang Li, Guangshan Wu, Qi Qin, Yi Tang · 2024 · Chinese Medical Journal
  45. GADD45G operates as a pathological sensor orchestrating reactive gliosis and neurodegeneration
    Tianjin Shen, Wenjiao Tai, Dongfang Jiang, Shuaipeng Ma, Xiaoling Zhong, Yuhua Zou, Chun‐Li Zhang · 2025 · Neuron
  46. Glial Cells in Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Frontiers
    Moumita Sil, Nabanita Mukherjee, Ishita Chatterjee, Ankita Ghosh, Arunava Goswami · 2025 · Journal of Molecular Neuroscience
  47. Targeting glial dysfunction in Alzheimer’s disease: insights into pathogenesis and emerging therapeutics
    Qing Zhu, Yu Song, Yuanyuan Qian, Ru Zhang, Jianhuang Xue, Yujun Hou · 2025 · Ageing and Neurodegenerative Diseases
  48. Advances of therapeutic strategies for Alzheimer’s disease
    Xing Guo, Rui-zhu Yue, Zhen Cui, Shuying Wang, Tian Jia, Wenqiang Li, Wei Zhang, Linlin Shan, Chaokun Li · 2025 · Journal of Neurology
  49. Oxaliplatin-artesunate conjugate intensifies suppression on colorectal cancer by boosting antitumor immunity
    Yehong Tan, Tao Yang, Siran Jiang, Shumeng Li, Linxiang Cai, Ying Wang, Zijian Guo, X M Wang · 2026 · Journal of Inorganic Biochemistry
  50. Associations of serum DNA methylation levels of chemokine signaling pathway genes with mild cognitive impairment (MCI) and Alzheimer’s disease (AD)
    Ting Zou, Xiaohui Zhou, Qinwen Wang, Yongjie Zhao, Meisheng Zhu, Lei Zhang, Wei Chen, Abuliz Pari, Haijun Miao, Keyimu Kabinur et al. · 2023 · PLoS ONE
  51. CD33 Ameliorates Surgery-Induced Spatial Learning and Memory Impairments Through TREM2
    Jie Zou, Yaxuan Wang, Xinyue Zhang, Xue Pan, Te Fang, Dasheng Cai, Lili Guo, Yu Li, Yi He, Xuezhao Cao · 2024 · Molecular Neurobiology
  52. Neuroimaging techniques, gene therapy, and gut microbiota: frontier advances and integrated applications in Alzheimer’s Disease research
    Haitao Wang, Shi Chen, Ling Jiang, Xiaozhu Liu, Rui Tang, Mingxi Tang · 2024 · Frontiers in Aging Neuroscience
  53. Alzheimer’s Disease Risk Variant rs3865444 in the CD33 Gene: A Possible Role in Susceptibility to Multiple Sclerosis
    Juraj Javor, Mária Bucová, Vladimı́ra Ďurmanová, Dominika Radošinská, Zuzana Párnická, Daniel Čierný, Egon Kurča, Daniela Čopíková‐Cudráková, Karin Gmitterová, Ivana Shawkatová · 2022 · Life
  54. Nitro Capsaicin Suppressed Microglial Activation and TNF-α-Induced Brain Microvascular Endothelial Cell Damage
    Sopana Jamornwan, Tanida Chokpanuwat, Kwanchanok Uppakara, Thanet Laorob, Uthai Wichai, Pimonrat Ketsawatsomkron, Witchuda Saengsawang · 2022 · Biomedicines
  55. Triggering Receptor Expressed on Myeloid Cell-2 Protects PC12 Cells Injury by Inhibiting BV2 Microglial Activation
    Jian-Wu Ni, Caixia Li, Xiongwei Chen, Wenpin Cai · 2022 · Neurology India
  56. Coupling of Alzheimer’s Disease Genetic Risk Factors with Viral Susceptibility and Inflammation
    Can Cao, Gaoshuang Fu, Ruodan Xu, Ning Li · 2023 · Aging and Disease
  57. The genetic risk factors, molecular pathways, microRNAs, and the gut microbiome in Alzheimer’s disease
    N S Aathira, Amanpreet Kaur, Arun Kumar, Ghulam Mehdi Dar, Nimisha, Abhay Kumar Sharma, Pinki Bera, Bhawna Mahajan, Atri Chatterjee, Sundeep Singh Saluja · 2025 · Neuroscience
  58. TREM2 deficiency aggravates neuroinflammatory response and cognitive impairment via disease-associated microglia in Parkinson's disease models
    Piao Zhang, Zhu Baoyu, Jiezhu Feng, Xiaomei Liang, Huang Peiting, Chentao He, Yiyu Deng, LU Jia-hong, Wang Lijuan, Yuhu Zhang · 2025 · Neurochemistry International
  59. Next-generation neurotherapeutics: mechanistic insights on monoclonal antibodies in Alzheimer’s disease
    Akhil Sharma, Thakur Gurjeet Singh · 2025 · Brain Research
  60. Advancement of disease-modifying therapy of Alzheimer’s disease: from the perspective of new revised criteria for diagnosis and staging of Alzheimer’s disease
    Jie Wu, Chaofan Geng, Liyang Liu, Yi Tang · 2025 · Medicine Plus
  61. Molecular Crossroads: Shared and Divergent Molecular Signatures in Alzheimer’s Disease and Dementia with Lewy Bodies
    Sandesh Neupane, Tibor Hortobágyi · 2025 · International Journal of Molecular Sciences
  62. Neuroimmune dysregulation in Alzheimer's disease: Mechanisms and therapeutic strategies
    Haili He, Shijie Zhu, Can Zhang, Hongyan Wang, Yuan Li, Haibing Qian · 2026 · Ageing Research Reviews
  63. Early amyloid‐induced changes in microglia gene expression in male APP / PS1 mice
    Takuya Oshima, Mandy S. J. Kater, Christiaan F. M. Huffels, Evelyn M. Wesseling, Jinte Middeldorp, Elly M. Hol, Mark H. G. Verheijen, August Benjamin Smit, Erik Boddeke, Bart J. L. Eggen · 2024 · Journal of Neuroscience Research
  64. Bringing Order out of Chaos: Establishing an Epistatic Relationship between CD33 and TREM2
    Timothy Y. Huang, Huaxi Xu · 2019 · Neuron
  65. Structural biology of cell surface receptors implicated in Alzheimer’s disease
    Stefan J. Hermans, Tracy L. Nero, Craig J. Morton, Jonathan H. Gooi, Gabriela A. N. Crespi, Nancy C. Hancock, Chen Gao, Kenta Ishii, Jasmina Markulić, Michael W. Parker · 2021 · Biophysical Reviews
  66. Innate Immune Mechanisms in the Central Nervous System
    Abhishek Shastri, Hadida Yasmin, Uday Kishore · 2025 · Advances in experimental medicine and biology
  67. Advances in Alzheimer’s disease: mechanistic insights and therapeutic targets
    Yu-Juan Jia, Yi‐Jun Ge, Bowei Li, Ying Yang, Huaqiu Chen, Jie Liu, Junhong Guo, Jin‐Tai Yu, Keqiang Ye, Jian‐Zhi Wang et al. · 2026 · Science China Life Sciences
  68. AI reveals insights into link between CD33 and cognitive impairment in Alzheimer’s Disease
    Tamara Raschka, Meemansa Sood, Bruce T. Schultz, Aybuge Altay, Christian Ebeling, Holger Fröhlich · 2023 · PLoS Computational Biology
  69. Neurogenomics of Alzheimer's disease (AD): An Asian population review
    Valentinus Besin, Farizky Martriano Humardani, Lisa Thalia Mulyanata · 2023 · Clinica Chimica Acta
  70. Genetic variability associated with OAS1 expression in myeloid cells increases the risk of Alzheimer’s disease and severe COVID-19 outcomes
    Naciye Magusali, Andrew C. Graham, Thomas M. Piers, Pantila Panichnantakul, Ümran Yaman, Maryam Shoai, Regina Hertfelder Reynolds, Juan Antonio Botía, Keeley J. Brookes, Tamar Guetta‐Baranes et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  71. Chemokine receptor 5 signaling in PFC mediates stress susceptibility in female mice
    Hsiao‐Yun Lin, Flurin Cathomas, Long Li, Romain Durand-de Cuttoli, Christopher A. Guevara, Çiğdem Sevim Bayrak, Qian Wang, Swati Gupta, Kenny L. Chan, Yusuke Shimo et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  72. Interplay between CD33 and TREM2 in Alzheimer’s Disease: Potential Mechanistic Insights into Microglial Function in Amyloid Pathology
    Elizabeth Toyin Akinluyi, Kei Takahashi, Meghan G. Connolly, Wayne W. Poon, Matthew Scott Macauley · 2025 · ACS Chemical Neuroscience
  73. The Spectrum of Microglia: Decoding Heterogeneity and Plasticity for Therapeutic Gain in Neurological Disorders
    Cheng Gao, Zhehao Lin, Yuxinyue Chen, Rui Gan, Ke Wang, Xiaoyu He, Haijun Han · 2025 · Neuropharmacology and Therapy
  74. Parkinson’s disease: spatiotemporal regulation and therapeutic prospects of TREM2-mediated microglial responses
    Keyuan Hou, Zhaowu An, Yuxiang Xu, Jing Wang, Meiru Zhou, Ye Liu, Xianfeng Zhu, Jianshe Wei · 2026 · npj Parkinson s Disease
  75. The Function of Microglia in Cognitive Impairment Influenced by Sleep Deprivation
    Jiping Jiang, Min Li, Yulong Xia, Wei We, Sheng Li, Xiao Wu, Sen Li, Houping Xu · 2026 · Cellular and Molecular Neurobiology
  76. Alteration of Cognitive Function in Aging and Alzheimer’s Disease Mice Is Related to Dysfunction of the Neuroimmune System
    Wanrong Jiang, Wei Wu, Li‐Jie Yang, Wanzhexi Yang, Qing Tian, Zhaohui Yao · 2023 · Journal of Alzheimer s Disease
  77. Exploring the vital role of microglial membrane receptors in Alzheimer’s disease pathogenesis: a comprehensive review
    JUN-FENG ZHAO, YI-RAN JIANG, TIAN-LIN GUO, YONG-QING JIAO, XUN WANG · 2024 · Biocell
  78. Neuroimmune Dysfunction in Alzheimer’s Disease and Other Forms of Dementia
    Takuya Yamane, Takeshi Yoshioka, Yusuke Shimo · 2024 · Chemical and Pharmaceutical Bulletin
  79. Microglia and Sleep Disorders
    Katherine Picard, Kira Dolhan, Jyoti J. Watters, Marie‐Ève Tremblay · 2024 · Advances in neurobiology
  80. Druggable genome-wide Mendelian randomization identifies therapeutic targets for metabolic dysfunction-associated steatotic liver disease
    Xiaohui Ma, Li Ding, Shuo Li, Fan Yu, Xin Wang, Yitong Han, Hengjie Yuan, Longhao Sun, Qing He, Min Liu · 2025 · Lipids in Health and Disease
  81. CD33 polymorphisms and Parkinson’s disease Parkinson’s disease in northern Chinese Han population: A case-control study
    Qing Tian, Xiaohui Sun, Chengqian Li, Yong Yang, Binghui Hou, Anmu Xie · 2023 · Neuroscience Letters
  82. Synergistic associations of CD33 variants and hypertension with brain and cognitive aging among dementia‐free older adults: A population‐based study
    Min Zhu, Xunyao Tian, Xiaodong Han, Yixun Ma, Wenxin Fa, Nan Wang, Rui Liu, Yi Dong, Yifei Ren, Cuicui Liu et al. · 2024 · Alzheimer s & Dementia
  83. Navigating the blurred boundary: Neuropathologic changes versus clinical symptoms in Alzheimer’s disease, and its consequences for research in genetics
    Catarina Xavier, Nádia Pinto · 2025 · Journal of Alzheimer s Disease
  84. Facilitating microglial phagocytosis by which Jiawei Xionggui Decoction alleviates cognitive impairment via TREM2-mediated energy metabolic reprogramming
    Wen Wen, Jie Chen, Junbao Xiang, Shiqi Zhang, Jingru Liu, Jie Wang, Ping Wang, Shijun Xu · 2025 · Chinese Journal of Natural Medicines
  85. Treating the immune system to repair the brain
    Michal Schwartz, Tommaso Croese · 2026 · Science Translational Medicine
  86. A systems biology-based identification and in vivo functional screening of Alzheimer’s disease risk genes reveal modulators of memory function
    Adam D. Hudgins, Shiyi Zhou, Rachel N. Arey, Michael G. Rosenfeld, Coleen T. Murphy, Yousin Suh · 2024 · Neuron
  87. L1CAM mimetic compound duloxetine improves cognitive impairment in 5xFAD mice and protects Aβ1-42-damaged HT22 cells
    Hanyu Chen, Zhou Fang, Stanley Li Lin, Melitta Schachner · 2025 · European Journal of Pharmacology
  88. Targeting the immune system towards novel therapeutic avenues to fight brain aging and neurodegeneration
    Javier María Peralta Ramos, Denise Kviatcovsky, Michal Schwartz · 2022 · European Journal of Neuroscience
  89. Alzheimer’s Disease: Causes, Mechanisms, and Steps Toward Prevention
    Se Hoon Choi, Rudolph E. Tanzi · 2020 · Oxford University Press eBooks
  90. Distinct effects of disease-associated TREM2 R47H/+ and T66M mutations on iPSC-derived microglia
    Jay Penney, William T. Ralvenius, Anjanet R. Loon, Oyku Cerit, Vishnu Dileep, Blerta Milo, Hannah Woolf, Li‐Huei Tsai · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  91. Alzheimer’s disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice
    Ghazaleh Eskandari‐Sedighi, Madeline C. Crichton, Sameera Zia, Erik Gomez, Chris D. St. Laurent, Leonardo M. Cortez, Zain H. Patel, Gaurav Sidhu, Susmita Sarkar, Vivian Aghanya et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  92. Co-regulation of microglial subgroups in Alzheimer’s amyloid pathology: Implications for diagnosis and drug development
    Yu Zhou, Yukuan Huang, Yangchang Fan, Feng Xue · 2025 · PLoS ONE
  93. Understanding Neurodegenerative Diseases From the −Omics Perspective: Lessons Learnt
    Laura Ibáñez, Cyril P. Pottier, Aleksandra Beric, Daniel Western, Muhammad Ali, Carlos Cruchaga · 2026 · Annals of Neurology
  94. Neuroinflammation in Alzheimer’s Disease (AD) and Glioblastoma (GBM): Shared Mechanisms and Therapeutic Insights
    Karolina Mikołajczak, James Chmiel, Jerzy Leszek · 2026 · Cells
  95. Development of early biomarkers of Alzheimer's disease: A precision medicine perspective
    Sumit Sarkar, Nikita Das, Kumar Sambamurti · 2022 · Elsevier eBooks
  96. Emerging Microglial Therapies and Targets in Clinical Trial
    Ling Yan, Andrea Crotti · 2024 · Advances in neurobiology
  97. MicroRNA‐429 Inhibits Microglial Inflammation by Targeting IKKβ Through the NF‐κB Pathway
    Zhongling Ke, Yanhui Chen, Xiaoxia Lin, Jilong Jiang · 2025 · Mediators of Inflammation
  98. 3D Alzheimer's disease in a dish: Implications for drug discovery
    Luisa Quinti, Joseph Park, Emma Brand, Rudolph E. Tanzi, Doo Yeon Kim · 2020 · Elsevier eBooks
  99. Sex differences in microglia as a risk factor for Alzheimer’s disease
    Charlotte Isabelle Delage, Danielle Nicole Rendina, Karen E. Malacon, Marie‐Ève Tremblay, Staci D. Bilbo · 2021 · Elsevier eBooks
  100. Advance of immune checkpoint inhibitors in CNS disease
    Jianru Sun, Xiangqi Shao, Xue Wang, Fan Liu · 2023 · Human Brain